Skip to main content

Article Category

News

Article available in the folowing languages:

Cancer research tender announced

The European Commission's Joint Research Centre is inviting tenders for a study on 'induction of conformational changes in p53 mutants and modulation of sensitivity to selective anti-cancer drugs.' The study should aim to develop an in vitro endpoint and to evaluate the poten...

The European Commission's Joint Research Centre is inviting tenders for a study on 'induction of conformational changes in p53 mutants and modulation of sensitivity to selective anti-cancer drugs.' The study should aim to develop an in vitro endpoint and to evaluate the potency of new anti-cancer drugs. For further information, please contact: European Commission Joint Research Centre Institute for Health and Consumer Protection Validation of Biomedical Testing Method Unit (ECVAM) Dr Laura Gribaldo TP 580 via Enrico Fermi 1 I-21020 Ispra (VA) Fax +39-0332-4336